News

Healthcare Dive2h
Evernorth reaches deals with Novo Nordisk, Eli Lilly to cap GLP-1 copays
The agreements cap monthly out-of-pocket costs for Zepbound and Wegovy at $200 and more deeply discount the drugs for ...
StockStory.org on MSN2h
Why Hims & Hers Health (HIMS) Stock Is Falling Today
What Happened? Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 6.3% in the afternoon session after Cigna ...
Fierce Healthcare1d
New Evernorth program to cap out-of-pocket costs for Wegovy, Zepbound at $200
Cigna's Evernorth is rolling out a new pharmacy benefit management program that caps members' monthly cost for key GLP-1 ...
Managed Healthcare Executive8h
Evernorth to Cap Out-of-Pocket Cost for Wegovy and Zepbound at $200
Health plan sponsors are also expected to see a reduction in the net cost per prescription of GLP-1 medications to treat obesity.
Cigna takes different approach with GLP-1s, more favorable for Eli Lilly
Cigna’s Evernorth has introduced a new pharmacy benefit that caps out-of-pocket costs for GLP-1 weight loss medications at $200 per month, in a move analysts say is more favorable for Eli Lilly ...
Modern Healthcare1d
Cigna debuts GLP-1 copay cap
Cigna subsidiary Evernorth Health Services will automate prior authorizations for GLP-1 weight-loss drugs under a new program ...
Explore more
30 affordable apartments to come to Rutland, developers say
Community leaders and members of Cornerstone Housing Partners, along with Evernorth, the owners and developers of a ...
Evernorth Launches New Benefit Option That Drives Lower Net Cost for Weight Loss Medicines and Limits Patient Cost to No More Than $200 Per Month
Evernorth, the health services division of The Cigna Group (NYSE: CI) announced a first-of-its-kind pharmacy benefit offering that make weight loss medications WEGOVY® and ZEPBOUND® more available to ...